Search results for "reduction"

showing 10 items of 2058 documents

Development of an Antifungal and Antimycotoxigenic Device Containing Allyl Isothiocyanate for Silo Fumigation

2019

The aims of this study were to evaluate the antifungal activity of the bioactive compound allyl isothiocyanate (AITC) against Aspergillus flavus (8111 ISPA) aflatoxins (AFs) producer and Penicillium verrucosum (D-01847 VTT) ochratoxin A (OTA) producer on corn, barley, and wheat. The experiments were carried out initially in a simulated silo system for laboratory scale composed of glass jars (1 L). Barley and wheat were contaminated with P. verrucosum and corn with A. flavus. The cereals were treated with a hydroxyethylcellulose gel disk to which 500 &micro

Ochratoxin AAflatoxinAntifungal AgentsInformation siloHealth Toxicology and MutagenesisFumigationlcsh:MedicineAspergillus flavusToxicology01 natural sciencesZea maysArticleAITCchemistry.chemical_compound0404 agricultural biotechnology<i>Penicillium verrucosum</i>AflatoxinsIsothiocyanatesPenicillium verrucosumFood scienceTriticum<i>Aspergillus flavus</i>2. Zero hungerbiologyChemistrymycotoxin reduction010401 analytical chemistrylcsh:RPenicilliumfood and beveragesAgricultureHordeumPenicillium verrucosum04 agricultural and veterinary sciencesbiology.organism_classificationAllyl isothiocyanate040401 food scienceOchratoxinsBioactive compoundfungal growth reduction0104 chemical sciencesFumigationAspergillus flavusToxins
researchProduct

A fully automated method for accurate measurement of geometrical distortion in magnetic resonance imaging of a 3D-lattice phantom

2019

Abstract This paper describes an automated method for extracting the apparent positions of fiducial points from 2D or 3D images of a phantom. We consider a 3D-lattice phantom for two main reasons: first, ease of manufacture and isotropy of its structure with respect to coordinate projections; second, a connected structure allowing to uniquely assess the adjacency relationship between fiducial points even if geometric distortions arising from main magnet inhomogeneity and gradient fields non-linearity is severe as observed in open-bore systems. In order to validate our proposed method and compare different choices for the parameters of our phantom (i.e. number and distance between grids and …

Offset (computer science)RegistrationImage qualityComputer scienceBiomedical EngineeringBiophysicsImage enhancement/restoration (noise and artifact reduction)Signal-To-Noise RatioImaging phantomPattern Recognition Automated030218 nuclear medicine & medical imaging03 medical and health sciencesImaging Three-Dimensional0302 clinical medicineSoftwareRobustness (computer science)HumansComputer SimulationRadiology Nuclear Medicine and imagingMagnetic resonance imaging (MRI)Fiducial point localizationElectronic Data ProcessingPhantoms ImagingSettore ING-INF/03 - Telecomunicazionibusiness.industryAirSpherical harmonicsModels TheoreticalMagnetic Resonance ImagingPhantom designPersonal computerAdjacency listbusinessAlgorithmSoftware030217 neurology & neurosurgeryMagnetic Resonance Imaging
researchProduct

Effect of storage on quality parameters and phenolic content of Italian extra-virgin olive oils

2019

The quality of extra virgin olive oils is affected mainly by hydrolytic and oxidative reactions. The present paper investigated the changes of major and minor components and oxidation indices of three monovarietal extra virgin olive oils after 18 months of storage at room temperature and in dark glass bottles conditions. After storage, the basic quality parameters such as free acidity, peroxide values, extinction coefficients, fatty acids composition, chlorophyll and carotenoid content, did not exceed the upper limits set by European Community Regulations for extra-virgin olive oils. Given the importance of the phenolic fraction, UHPLC-HESI-MS metodology was used. A decrease in 3,4-DHPEA-ED…

OleacinIridoid GlucosidesUHPLC-HESIMSFraction (chemistry)Plant Science01 natural sciencesBiochemistryPeroxideAnalytical Chemistrychemistry.chemical_compoundHydrolysisUHPLC-HESI-MSGlucosidesPhenolsOleuropeinFood QualityIridoidsFood scienceOlive OilCarotenoidPyranschemistry.chemical_classification010405 organic chemistryFatty AcidsOrganic Chemistry0104 chemical sciencesTyrosol010404 medicinal & biomolecular chemistryFood StorageItalychemistryoleochantalChlorophyllHydroxytyrosoloil agingOxidation-ReductionhydroxytyrosolNatural Product Research
researchProduct

Homogeneous Metal-Based Catalysis in Supercritical Carbon Dioxide as Reaction Medium

2016

Above 31.1 degrees C and 73.8 bar, carbon dioxide reaches the supercritical state, being transformed into a fluid (scCO(2)) that has attracted interest in the last few decades as reaction medium for several transition-metal-catalyzed organic transformations. The main feature of this fluid rests on its capability to dissolve large amounts of other gases such as hydrogen, carbon monoxide, ethylene, or even methane and light alkanes. In this manner, very high concentrations of these reactants are available for catalysis. In this contribution a review of the main achievements of the use of transition-metal complexes as catalysts in scCO(2) is presented.

Olefin metathesisInorganic chemistryHomogeneous catalysis010402 general chemistry01 natural sciencesC-C bond formationCatalysisMethaneCatalysischemistry.chemical_compoundSupercritical carbon dioxideOxidationC-H activationCycloadditionElectrochemical reduction of carbon dioxideSupercritical carbon dioxide010405 organic chemistryChemistryGeneral ChemistryHomogeneous catalysisSupercritical fluid0104 chemical sciencesCarbon dioxideHydroformylationHydrogenationCarbon monoxide
researchProduct

Non-Hodgkin Lymphoma, Body Mass Index, and Cytokine Polymorphisms: A Pooled Analysis from the InterLymph Consortium.

2015

Abstract Background: Excess adiposity has been associated with lymphomagenesis, possibly mediated by increased cytokine production causing a chronic inflammatory state. The relationship between obesity, cytokine polymorphisms, and selected mature B-cell neoplasms is reported. Method: Data on 4,979 cases and 4,752 controls from nine American/European studies from the InterLymph consortium (1988–2008) were pooled. For diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL), and chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL), joint associations of body mass index (from self-reported height and weight) and 12 polymorphisms in cytokines IL1A (rs1800587), IL1B (rs16944,…

OncologyAdultMalemedicine.medical_specialtyEpidemiologyChronic lymphocytic leukemiamedicine.medical_treatmentFollicular lymphomaBiologyArticleBody Mass IndexYoung Adultimmune system diseasesRisk FactorsInternal medicinemedicineHumansGenetic Predisposition to DiseaseLymphangiogenesisAdiposityAgedRetrospective StudiesPolymorphism GeneticAbsolute risk reductionDNA NeoplasmMiddle Agedmedicine.diseaseObesityLymphomaCytokineOncologyIL1AImmunologyCytokinesFemaleLymphoma Large B-Cell DiffuseBody mass indexCancer epidemiology, biomarkersprevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
researchProduct

Analysis of relapse after transplantation in acute leukemia: A comparative on second allogeneic hematopoietic cell transplantation and donor lymphocy…

2018

Relapse of acute leukemia (AL) after allogeneic hematopoietic cell transplantation (Allo-HCT) entails a dismal prognosis. In this scenario, donor lymphocyte infusions (DLIs) and second Allo-HCT are two major approaches. We compared outcomes of AL patients treated for relapse with DLI or second Allo-HCT after receiving debulking therapy. In total, 46 patients were included in the study; 30 (65%) had acute myeloid leukemia and 16 (35%) had acute lymphoblastic leukemia. The median age was 38 years (range 4-66). Twenty-seven patients received a second Allo-HCT and 19 patients received DLI. The median follow-up of the cohort was 273 days (range 9-7013). Overall survival (OS), disease-free surviv…

OncologyMaleCancer ResearchTransplantation Conditioningmedicine.medical_treatmentSalvage therapyHematopoietic stem cell transplantationKaplan-Meier EstimateCohort Studies0302 clinical medicineRecurrencehemic and lymphatic diseasesCumulative incidenceChildAcute leukemiaUnivariate analysisHematopoietic Stem Cell TransplantationMyeloid leukemiaHematologyMiddle AgedPrecursor Cell Lymphoblastic Leukemia-LymphomaAllograftsLeukemiaLeukemia Myeloid Acutesurgical procedures operative030220 oncology & carcinogenesisChild PreschoolLymphocyte TransfusionFemaleLeukocyte Reduction ProceduresAdultmedicine.medical_specialtyAdolescentGraft vs Leukemia EffectDisease-Free Survival03 medical and health sciencesYoung AdultInternal medicineGeneticsmedicineHumansMolecular BiologyAgedRetrospective StudiesImmunosuppression TherapySalvage Therapybusiness.industryCell Biologymedicine.diseaseTransplantationbusiness030215 immunologyExperimental hematology
researchProduct

EndoPredict improves the prognostic classification derived from common clinical guidelines in ER-positive, HER2-negative early breast cancer

2012

Background In early estrogen receptor (ER)-positive/HER2-negative breast cancer, the decision to administer chemotherapy is largely based on prognostic criteria. The combined molecular/clinical EndoPredict test (EPclin) has been validated to accurately assess prognosis in this population. In this study, the clinical relevance of EPclin in relation to well-established clinical guidelines is assessed. Patients and methods We assigned risk groups to 1702 ER-positive/HER2-negative postmenopausal women from two large phase III trials treated only with endocrine therapy. Prognosis was assigned according to National Comprehensive Cancer Center Network-, German S3-, St Gallen guidelines and the EPc…

Oncologymedicine.medical_specialtyEndoPredict geneAntineoplastic Agents HormonalReceptor ErbB-2Populationadjuvant treatmentBreast NeoplasmsKaplan-Meier EstimateAnastrozoleRisk AssessmentDisease-Free SurvivalBreast cancerInternal medicineBreast CancerexpressionAntineoplastic Combined Chemotherapy ProtocolsNitrilesmedicineHumanseducationSurvival analysisRetrospective Studieseducation.field_of_studybusiness.industryendocrine therapyAbsolute risk reductionRetrospective cohort studyHematologyOriginal ArticlesMiddle AgedTriazolesmedicine.diseasePrognosisChemotherapy regimenSurgeryTamoxifenTreatment OutcomeOncologyReceptors EstrogenChemotherapy AdjuvantPractice Guidelines as TopicFemaleBreast diseasebusinessRisk assessmentAnnals of Oncology
researchProduct

Stage IV breast cancer: a population-based study about prognostic factors according to HER2 and HR status

2015

International audience; We aim to describe trends in net survival (NS) and to assess the prognostic factors among women with de novo metastatic breast cancer (MBC) according to human epidermal growth factor receptor 2 (HER2) and hormone receptor (HR) status. Data on women suffering from de novo MBC and diagnosed from 1998 to 2009 were provided by the Côte-d'Or breast cancer registry. NS was described using the Pohar Perme estimator and prognostic factors were investigated in a generalised linear model. We identified 232 patients (mean age = 64.7). Median NS was 29.2 months, 1- and 5-year NS were 76% and 26% respectively. The survival trend in patients with HER2-positive tumours who did not …

Oncologymedicine.medical_specialtyReceptor ErbB-2Antineoplastic AgentsBreast NeoplasmsTriple Negative Breast NeoplasmsLower riskBreast cancerTrastuzumabInternal medicinemedicineHumansNeoplasm Metastasisskin and connective tissue diseasesAgedNeoplasm StagingGynecologyregisterbusiness.industryCarcinoma Ductal BreastAge FactorsAbsolute risk reductionhormone receptorsCancerTriple Negative Breast NeoplasmsMiddle AgedTrastuzumabHER2 receptorsPrognosismedicine.diseaseMetastatic breast cancerConfidence interval3. Good healthpopulation-basedCarcinoma LobularReceptors EstrogenOncologyLinear ModelsFemalemetastatic breast cancernet survivalReceptors Progesteronebusiness[SDV.MHEP]Life Sciences [q-bio]/Human health and pathologymedicine.drug
researchProduct

Simplifying the dental/periodontal management of patients with metabolic bone fragility receiving treatment with denosumab

2020

Denosumab (DNB) is a bone-targeted medication used to preserve structural integrity and minimise the risk of fragility fractures in metastatic cancer and metabolic bone disorders. DNB targets and binds RANK Ligand, inhibiting osteoclast maturation, function, and survival. In contrast with nitrogen-containing bisphosphonates (N-BPs), DNB does not bind to hydroxyapatite and incorporate into bone; thus, bone cellular remodelling recovers rapidly after drug suspension. Denosumab has benn linked to the occurrence of osteonecrosis of the jaw (MRONJ), a uncommon but severe oral side effect with a higher prevalence in metastatic cancer patients than in patients with metabolic bone fragility. Althou…

Oncologymedicine.medical_specialtySide effectbusiness.industrymedicine.medical_treatmentosteonecrosis of the jawsCancerdental managementdenosumabmedicine.diseaseMetabolic Bone DisorderOsteoclast maturationDenosumabdental management denosumab osteonecrosis of the jawsInternal medicineMedicineDosingbusinessOsteonecrosis of the jawReduction (orthopedic surgery)medicine.drug
researchProduct

&#x0D; Consistency and Proportionality in Policy Decision-Making in Blood Safety: the Case for an All-Apheresis Platelet Supply in Germany

2013

SUMMARY Recently, German investigators presented the first mathematical model finding a significant increase in the risk of HIV, HCV, and HBV transmission when pools of 4 whole-blood-derived buffy-coat platelets, rather than 1 singledonor (apheresis) component, are used to provide one platelet dose. Based, in both cases, on mathematical models employing the incidence/window-period method, the relative risk of transmission from pooled versus apheresis platelets (2.2 or 2.75 for HIV, 2.7 or 3.375 for HCV, and 3.2 or 4.0 for HBV, with pools of 4 or 5 concentrates, respectively) is similar to the difference in risk before (versus after) introduction of HIV-1 and HCV RNA screening. The absolute …

Oncologymedicine.medical_specialtybusiness.industryHuman immunodeficiency virus (HIV)Viral transmissionvirus diseasesPathogen reductionmedicine.disease_causeGeneral Biochemistry Genetics and Molecular BiologyPolicy decisionInternal medicineRelative riskImmunologymedicineBlood safetyPlateletbusinessModel findingClinical Laboratory
researchProduct